Nike's turnaround is looking much longer than bulls expected, and about 17x forward earnings is not cheap for a business growing low single digits. China sales fell 26% FX-neutral while Adidas' Greater China sales grew 15%, pointing to a Nike problem, not a China problem. Sportswear fell low double digits with Dunk revenue down about 50%, Jordan fell mid-teens, and most PACE savings are expected only in FY29-30; Performance grew high single digits. The must-buy price is $25. x.com  x.com  x.com 

Nike is a damaged business, not just a damaged stock, so buying the dip is a mistake; a falling price only works when the business is still growing. Sportswear, just under half of revenue, is down low double digits, China is losing ground to local brands, and guided earnings don't cover the dividend this year. Insider buying hasn't helped: Tim Cook and directors bought around $59 in December 2025, Cook and the CEO near $42 in April, and shares now sit near $32. x.com  x.com 

Nike's brand concerns look priced in; stabilization, not sudden revenue acceleration, is what the speculative long needs. A few good campaigns and a return to large stores could help, though China consumers will be a drag. Short-term EPS is a poor indicator, and customers may return after trying other brands. x.com  x.com 

Nike's 29x P/E even after a steep share-price decline leaves it expensive enough to short. x.com 

Nike hit its lowest level since 2014 because its turnaround is improving in wholesale but still deteriorating almost everywhere else. Wholesale grew 4% in Q4, but Nike Direct fell 7%, digital 12% and footwear 4%, while China revenue dropped 17% as On and HOKA gain share. About 900 bps of gross-margin improvement and $0.52 of the $0.72 EPS came from tariff recoveries, and FY26 free cash flow fell 33% to $2.2B. The market wants proof that Direct, digital, China and margins can recover. x.com 

Nike under $40 is getting very interesting because expectations have fallen so low, often where the best risk/reward shows up. The stock closed at its lowest since 2014, about 78% below its all-time high. The turnaround is not finished: FY26 revenue was basically flat, Nike Direct is still shrinking and China remains a major problem. But wholesale revenue grew 6% for the year as Nike rebuilds retailer relationships. This is not a call on the bottom. x.com 

Nike's latest report confirms a structural unwinding, not a temporary dip, despite the EPS beat. The $0.48 versus $0.44 beat came from expense cuts, a lower tax rate and a lowered bar, while revenue missed and management warned of a high-single-digit full-year sales decline. NIKE Direct fell 8%, digital 13% and owned stores 5%, Greater China plunged 22%, and consumers are fleeing to On, Hoka and Adidas. Cost cuts can't restore cultural heat, and earnings power looks halved. x.com 

Nike looks overvalued at about 25.6x forward earnings for a business guiding to high-single-digit revenue declines. At $32 on $1.25 of EPS, per the lowered guidance @TrendSpider reports, plus a 5% dividend, tobacco stocks like Altria should triple if that is the going rate for shrinking sales. Nike does not merit a tobacco multiple: it angered its distributors, faces more premium rivals and new entrants, has less loyal customers, is no government-mandated duopoly and pays for costly marketing. … Show more

Nike's valuation pays investors to wait for a turnaround that will take longer than expected. It trades at just 16x earnings, near its lowest valuation ever, with a roughly 5% dividend yield, and would need a 127% rally to regain its 200-week moving average. Revenue is projected to fall another 4% in FY2027, but the business will grow again; the market prices it as if it were disappearing. Unlike Novo Nordisk, Nike faces no patent cliff. x.com  x.com 

Nike could be re-rated lower as an apparel company with falling revenue and EPS that is struggling to show CEO Elliott Hill's turnaround is taking root after two years. Q1 revenue missed at $11.21B, FY27 revenue is guided down by a high-single-digit percentage versus a 2% expected decline, and adjusted EPS guidance of $1.15-$1.35 sits well below the $1.65 consensus, with weakness in China, sportswear and Jordan. Its 26.4x 2027 P/E is low only versus its ~30x history. x.com  x.com